A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
Clinical trial NCT04206553 · COMPLETED
Trial details
- NCT number
- NCT04206553
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2024-07-12
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.